scispace - formally typeset
H

Heyu Ni

Researcher at University of Toronto

Publications -  167
Citations -  7908

Heyu Ni is an academic researcher from University of Toronto. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 46, co-authored 158 publications receiving 6724 citations. Previous affiliations of Heyu Ni include University of Manitoba & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen

TL;DR: Surprisingly, mice deficient in both vWF and Fg successfully formed thrombi with properties characteristic of both mutations, leading to vessel occlusion in the majority of vessels.
Journal ArticleDOI

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo

TL;DR: The results suggest that platelets express various TLRs and that the functional significance of one of these, TLR4, appears to be a role in the modulation of LPS-induced thrombocytopenia and TNF-alpha production, and implicates platelets as important mediators of innate immune responses against invading microorganisms.
Journal ArticleDOI

Plasma fibronectin promotes thrombus growth and stability in injured arterioles

TL;DR: It is concluded that FN plays a significant role in thrombus initiation, growth, and stability at arterial shear rates and that deficiency in each of the three platelet ligands has its own specific impact on platelet plug formation.
Journal ArticleDOI

Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond

TL;DR: Recent studies demonstrated that fibrinogen-independent platelet aggregation occurs in both gene deficient animals and human patients under physiological and pathological conditions, which indicates that other unidentified platelet ligands may play important roles in thrombosis and might be novel antithrombotic targets.